Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;102(2):e65-e68.
doi: 10.3324/haematol.2016.152371. Epub 2016 Oct 14.

The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates

Mohib Uddin  1 , Catherine Betts  2 , Ian Robinson  3 , Anna Malmgren  1 , Charles Humfrey  3
Affiliations

The chemokine CXCR2 antagonist (AZD5069) preserves neutrophil-mediated host immunity in non-human primates

Mohib Uddin et al. Haematologica. 2017 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
CXCL8 and G-CSF plasma concentrations in cynomolgus monkeys during the 39 week dosing interval. Samples of venous whole blood taken into K3-EDTA anticoagulant were obtained from conscious male (open bars) and female monkeys (closed bars) at week 26 (panels A & C) and week 32 (panels B & D). CXCL8 and G-CSF levels in samples collected at the end of compound treatment (week 40) were generally comparable to those obtained for week 32 (data not shown). Cytokine levels were determined by multiplex bead array (Millipore). Results are expressed as mean ± S.D. n=8 monkeys per treatment group. *P<0.05 and **P<0.01 vs. concurrent vehicle-treated animals (0 mg/kg/day) as determined by Shirley’s nonparametric test. IL-8: interleukin-8; G-CSF: granulocyte colony-stimulating factor.
See this image and copyright information in PMC

References

    1. Nathan C. Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol. 2006;6(3):173–182. - PubMed
    1. Baggiolini M. Chemokines in pathology and medicine. J Intern Med. 2001;250(2):91–104. - PubMed
    1. Proost P, Wuyts A, van Damme J. The role of chemokines in Inflammation. Int J Clin Lab Res. 1996;26(4):211–223. - PubMed
    1. De Soyza A, Pavord I, Elborn JS, et al. A randomised, placebo-controlled study of the CXCR2 antagonist AZD5069 in bronchiectasis. Eur Respir J. 2015;46(4):1021–1032. - PubMed
    1. Moss RB, Mistry SJ, Konstan MW, et al. Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis. J Cyst Fibros. 2013;12(3):241–248. - PubMed

MeSH terms

Substances

LinkOut - more resources